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Abstract 
Objectives: To evaluate the impact of pulmonary rehabilitation on survival and fall 
(including balance) in patients with chronic obstructive pulmonary disease (COPD) at 
stability.  
Design: Systematic Review.  
Methods: OVID, MEDLINE, EMBASE, and Cochrane Collaboration Library were 
searched for literature dating from January 1980 up to November 2014 as well as an 
update in October 2015. Two reviewers screened titles, abstracts and full text records, 
extracted data and assessed studies for risk of bias; any disagreements were resolved by 
a third member of the team, and consensus was always sought.  
Results: Initial searches yielded 3216 records but after review, only 7 studies were 
included and no studies focused solely on falls. Two cohort studies found some positive 
benefits of pulmonary rehabilitation on balance but the results were inconsistent across 
the studies. Regarding survival, two randomised controlled trials were conducted; one 
study showed significant survival benefit at 1 year while the other one showed non-
significant survival benefit at 3 years. Neither were adequately powered and in both, 
survival was a secondary outcome.  
Conclusions: There was only limited inconclusive evidence to show that pulmonary 
rehabilitation has a significant beneficial effect on balance or survival.  
Keywords: COPD, Pulmonary Rehabilitation, Survival, Mortality, Fall, Balance 
Words: 191 
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Abbreviations Description 
ABC Activities-Specific Balance Confidence-Scale 
BBS Berg Balance Scale 
BESTtest Balance Evaluation Systems Test 
COPD Chronic Obstructive Pulmonary Disease 
FEV1 Forced Expiratory Volume in the First Second  
MCID Minimum Clinically Important Difference 
MDC Minimum Detectable Change 
NOS Newcastle-Ottawa Scale 
PR Pulmonary Rehabilitation 
RCT Randomized Control Trial 
TUG Time Up and Go-Test 
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Introduction 
Chronic obstructive pulmonary disease (COPD) is a heterogeneous inflammatory 
lung disease characterized by progressive airway obstruction. It is the third leading cause 
of death worldwide.[1] Comorbidities include cardiovascular disease, diabetes mellitus, 
osteoporosis, increased risk of fall, and depression. [2] In general, impaired mobility, 
muscle weakness, and impairment of balance due to chronic diseases are strong predictors 
of fall in adults;[3] recent studies have found that balance is impaired in patients with 
COPD.[4] A recent Cochrane systematic review showed evidence that falls in elderly can 
be prevented with exercise.[5] Exercise, with balance training, has been recommended in 
the guidelines for prevention of falls in older people with grade B evidence. [6]  
Pulmonary rehabilitation (PR) is an important part in the clinical management of 
COPD, and it includes education, exercise training, and psychological support [7]. There 
are demonstrable improvements in exercise tolerance, muscle strength, dyspnoea, quality 
of life in patients with COPD after PR, cemented in a Cochrane review[8] and the BTS 
guidelines[9]. Improving muscle strength and exercise tolerance through PR as well as 
the opportunity for educational support and improving confidence may well therefore 
improve risk of future falls. Given patients with COPD have a high prevalence of 
osteoporosis;[2] an increased risk of falls is of even more concern. Further quality of life 
in the older population as a whole is associated with falls.    
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Whilst a systematic review of six clinical trials has shown survival benefit in those 
undergoing pulmonary rehabilitation in patients with COPD after an acute exacerbation, 
[10] the situation in stable patients undergoing standard PR is uncertain. The BTS 
pulmonary rehabilitation guidelines document research recommendations and include 
need for research on comorbidities, preserving health, personalisation of PR and 
extending the outcomes used.[9] The aim of this study is to conduct a systematic review 
of published studies that evaluate the effect of a PR programme on stable patients with 
COPD to determine if there is benefit with regard to balance or falls, and survival. 
Method  
Searches were conducted through OVID on Medline, EMBASE, Cochrane 
Collaboration Library and the register of controlled trials from January 1980 until 
November 2014, and through an update in October 2015. The search yielded adult human 
studies on patients with COPD who have had standard PR not less than four weeks; the 
outcome measures were balance, fall, survival, and mortality.  The search was conducted 
with the University library services who approved the search terms and methodology 
structure. The search was limited to articles in “English” and “humans”.  
Using the PICOS (The population, intervention, comparison, outcome, and setting) 
model, the criteria were:  
1. The population: Stable adult patients with COPD.   
2. The intervention: Standard multidisciplinary PR of not less four weeks. 
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3. The comparator/control: Other patients with COPD did not have PR.    
4. The outcome: balance, fall, survival, mortality.  
5. The study design: Either cohort or clinical trials from 1980 onward.  
The following key words were used: “Pulmonary Rehabilitation”; “COPD” or “chronic 
obstructive pulmonary disease”, “chronic obstructive lung disease”, “Chronic 
bronchitis”, “emphysema”, “bronchitis”; “mortality” or “death”, “survival”, “survive”, 
“fall”, “faller”, “falling”, “accidental fall”, “balance”, “imbalance”. We conducted this 
review in accordance with the Preferred Reporting Items for Systematic Reviews and 
Meta-Analysis (PRISMA) guidelines.[11] [Online Supplement Table E1] 
Two reviewers independently assessed the titles and abstracts; they evaluated the 
full text studies based on outcome and type of rehabilitation program for at least 4 weeks. 
These studies were evaluated and selected independently for inclusion in the systematic 
review. Any disagreements were resolved by a third member of the team, and consensus 
was always sought. Additional studies were searched for the bibliographies and relevance 
of the retrieved articles. Studies that did not fulfil the selection criteria were excluded.  
Two reviewers independently extracted the full text of the included articles and 
recorded details on authorship, year of publication, study design, interventions, patient 
and outcome measures. Risk of bias was assessed using the Cochrane Collaboration’s 
‘Cochrane risk of bias tool (modified) for quality assessment of the randomized control 
trial (RCT)’ for sequence generation, allocation concealment, and blinding.[12]  The 
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Newcastle-Ottawa scale (NOS) was used to assess the methodology and quality of the 
cohort studies; the scale awards 4 points for selection, 2 points for comparability, and 3 
points for outcome - a score of 9 is the highest.[13]  
Results 
3216 citations were identified from the databases in the original search; seven 
studies that met the eligibility criteria of the review, of which 2 were randomized control 
trials and 5 were cohort studies, were selected.[14-20]  [Figure 1] The quality of the cohort 
studies, as assessed by the NOS with a mean score of 6 out of 9, with points loss due to 
sampling method or inadequate time for follow-up.[13] For the two randomized trials, the 
quality of the included studies’ reporting was high; allocation concealment and sequence 
generation were clearly described in both trials. But one trial did not use blinding while 
the other was only single-blinded. No quantitative analysis was performed due to the lack 
of data to comparable outcome data to combine. In general, the studies did not show major 
problems of bias, for detailed characteristics of the included studies and quality 
assessment for risk of bias, see Online Supplement Table E2-E8. 
[Figure 1] 
Fall / Balance 
There were no studies that report of the impact of PR on falls directly, while two cohort 
studies evaluated the effect of standard PR on balance in patients with COPD. [Table 1] 
Both studies assessed the balance tests using Minimum Detectable Change (MDC) as the 
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true change in the balance. The first cohort study by Beauchamp et al. [15] studied 29 
patients with COPD (pre- and post-PR), and found significant improvement in measures 
of balance, the Berg Balance Scale (BBS) [BBS mean difference=2.8 points; 95% CI (1.7 
to 3.8); P<0.001], and the Time Up and Go test (TUG), [TUG mean difference=-1.5s; 
95% CI (-2.4 to -0.5); P=0.003], but not for self-assessed balance confidence score as 
measured by Activities-Specific Balance Confidence Scale (ABC) [mean difference=4.8; 
95% CI (-1.0 to 10.7), p=0.1]. In the second study by the same authors [14], they 
conducted a randomized clinical trial comparing standard PR with PR + balance training. 
Based on our inclusion criteria we have taken only the control arm of this trial (PR) and 
treated as a cohort study. Here, patient inclusion criteria also included a self-reported 
decline in balance, fall in the last 5 years or a near fall. Within this control arm, 17 patients 
(pre- and post-PR program) were studied and this time the results showed no significant 
improvement in the BBS [mean difference=1.6 points; 95% CI (-0.26 to 3.46), p=0.07]; 
but there was significant improvement in ABC confidence [mean difference=13; 95% CI 
(3.72 to 22.27), p=0.014]. Here, the Balance Evaluation Systems Test (BESTtest) showed 
significant improvement as well [mean difference=6; 95% CI (3.39 to 8.60), p=0.0003].  
[Table 1] 
Survival 
Three cohort studies [16-18] [Table 2] and two randomized controlled trials [19, 
20] (Table 3) contributed to the mortality data with pulmonary rehabilitation. In 1996, a 
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cohort study by Gerardi [18] investigated survival in 158 patients (of which 87% had 
COPD)  who had completed the PR program, and the survival rate was 80% at 3 years 
after rehabilitation. In another cohort study by Bowen [16] in 2000 (of which 89% had 
COPD) the survival rate in 149 patients who completed the PR program was 95% at 1 
year, 92% at 2 years, 85% at 3 years, and 73% at 4 years after rehabilitation. In the third 
cohort study by Connor [17] in 2001 on 170 patients, the 1-year survival rate was slightly 
lower than Bowen’s study at 91%.  
Two randomized control trials [19, 20] compared the survival rate between PR 
and control groups [Table 2], where survival was a secondary outcome in both cases. In 
1995, Ries et al. [20] studied two groups of patients; 57 patients (rehab) received the 
standard PR program and 62 patients (control) received only the PR education 
component. They found at 3 years that 85% survived in the rehab group compared to 74% 
amongst the control group; and at 6 years, 67% in rehab and 56% in the control group 
survived. Although the PR survival was better, there was no significant difference in 
survival rate (Hazard ratio=0.74 [95% CI, 0.41 to 1.34; P = 0.32]). In the second trial in 
2000, Griffiths et al. [19] compared a standard rehab group (92 patients) with a control 
group (90 patients); survival was reported as a supplementary result of their study. By 
year 1 of the study, 94.5% survived in the rehab group compared to 90% in the control 
group, (P value=0.032).  
[Table 2] 
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[Table 3] 
  Discussion 
This systematic review identified a paucity of studies that focus on the effect of 
PR on falls, balance or survival. In the 2 studies that examined any potential benefit of 
PR on balance, the results were not consistent across the two studies even though each of 
them demonstrated a significant improvement in at least one of the balance scores. The 
survival in patients with COPD who had PR at clinical stability appeared to show some 
benefit however this was not always statistically significant. 
The identified studies on balance [14, 15] have small sample size and they have 
excluded patients with many comorbidities that could influence their balance. Small 
statistical differences in some of the balance tests were found but these were not 
consistent across the studies. Previous research have shown that patients with COPD have 
worse balance score on their BBS test compared to healthy individuals.[21, 22] . The 
balance tests used in the studies (BBS, TUG, and BESTest) and the ABC balance 
confidence are important as they have shown reliable and valid results for determining 
balance and fall risk in adults [23-26]. In addition, they have been used to evaluate the 
ability to maintain balance and quantify patients with COPD at risk of falling.[3, 27] Both 
cohorts used Minimum Detectable Change (MDC) instead of the Minimum Clinically 
Important Difference (MCID). “Statistically significant difference” does not necessarily 
mean “clinically important” in terms of a clinically demonstrable change. Recently, 
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Beauchamp carried out a secondary analysis to determine the MCID of the BBS, 
BESTest, and ABC.[28]  
Previous evidence has shown that exercise reduces falls in the elderly.[5] 
Furthermore, studies have found that standard PR with adding balance training 
component had a better effect on functional balance and muscle strength in patients with 
COPD which should, in turn lead to reduced falls.[29, 30] On the current evidence 
therefore, patients at risk of falls, undergoing PR should have a personalised balance 
training. 
Pulmonary rehabilitation has been associated with improved survival in patients with 
COPD after an acute exacerbation.[31] However, the evidence that PR is associated with 
improved survival in stable patients with COPD is not as clear. The RCTs included in this 
review were underpowered to show a difference in survival. They both showed improved 
survival but they were not both statistically significant. [19, 20]   In addition to the RCT’s 
we identified the three cohort studies that showed survival following PR, though it is 
difficult to then compare with other reports of survival in patients with COPD generally. 
The four year survival in a general cohort of patients with COPD was 81%,[32] in one 
study and as expected, varied according to severity of COPD in another study.[33] When 
assessed according to airflow obstruction alone, survival at 52 months was 75% for 
patients with stage I (FEV1> 50) and II (FEV1 36-50), and 48% for stage III (FEV1< 
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35).[33] Overall, although evidence on PR has shown significant improvement in the 
quality of life and dyspnoea, the outcomes of balance, fall, and survival are less clear.  
The main strength of this review was in the rigorous study selection process, and 
therefore it is unlikely to have missed any research in this area. The main limitation of 
this review was the lack of studies and evidence for evaluating the desired outcomes. 
Moreover, Gerardi[18] and Bowen[16] have included patients with diagnoses other than 
COPD, although the majority did have COPD. It was not possible to look at survival in 
those with COPD alone.  
In conclusion, this systematic review is unable to demonstrate sufficient evidence 
of the role of pulmonary rehabilitation in improving balance or survival in patients with 
COPD. Further studies with alternative strategies may need to be employed to determine 
the benefits of pulmonary rehabilitation particularly on survival as the short term benefits 
are from pulmonary are well established, and therefore unethical to with hold from 
patients.   
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Figure 1. Flow diagram of the selection process of studies included in the systematic 
review.   
Identified From Searches,  
Duplicates Removed 
n=3216 
Abstracts Review 
n=234 
Full Text Review 
n=19 
Excluded After Abstract Review 
n=215 
Included in the systemic review n=7 
Excluded After Title Review 
n=2982 
Excluded after full text review n=12 
4 were conference abstracts that had insufficient 
information and not been published fully; 2 studies 
had PR conducted before 1980, 2 had not reported 
relevant outcome; 4 were not multidisciplinary 
standard PR 
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Table 1. Two cohort studies assessing the impact of pulmonary rehabilitation on fall/balance 
Author/ 
Year 
PR site Inclusion Exclusion 
PR 
weeks 
PR 
Education 
PR Breath 
Tech 
PR Exercise 
Train 
Total No /Lost to follow up 
/Final No of patients 
Quality 
score* 
Outcome 
Mean difference 
(95% CI) 
P- value 
Beauchamp 
2010 
[15] 
Inpatient 
COPD (FEV1 <80% 
predicted and 
FEV1/forced vital 
capacity <70% 
predicted), smoking 
history >20 pack/year 
Cognitive impairment, 
symptomatic 
cardiovascular disease, 
musculoskeletal 
condition that limited 
mobility 
6 2/wk /30min Daily 4-5 times/ week 33 / 4 / 29 6 out of 9 
BBS 
2.8 
(1.7 to 3.8) 
P<0.001 
TUG 
-1.5 
(-2.4 to -0.5) 
P=0.003 
ABC 
4.8 
 (-1.0 to 10.7) 
P=0.10 
Beauchamp 
2013 
[14] 
Inpatient 
patients with COPD 
who reported decline in 
balance or fall in last 5 
years or a recent near-
fall 
Inability to communicate, 
comorbidity that  
influenced balance, 
musculoskeletal condition 
that severely limited 
mobility and balance 
6 2/wk /30min Daily 4-5 times/ week 18 / 1 / 17 7 out of 9 
BBS 
1.6 
 (-0.26 to 3.46) 
P=0.07 
BESTest 
6 
(3.39 to 8.60) 
P=0.0003 
ABC 
13 
 (3.72 to 22.27) 
P=0.014 
* Studies’ quality assessed by Newcastle-Ottawa scale. Characteristics of the studies [Appendix] 
Abb i: PR: pulmonary rehabilitation, wk: week, BBS: Berg Balance Scale, BESTest: Balance Evaluation Systems Test, ABC: Activities-Specific Balance Confidence scale, 
TUG: Timed Up and Go test. 
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Table 2. Cohort studies assessing the impact of pulmonary rehabilitation on mortality  
Author/ 
Year 
PR site Inclusion Exclusion 
PR 
weeks 
PR 
Education 
PR Breath 
Tech 
PR Exercise Train 
Total No / Lost follow up /  
Final No of patients 
Quality 
score* 
Duration of 
follow-up 
Survival Rate 
Gerardi 
1996 
[18] 
Outpatient 
Pt. completed PR 
from Nov1989 to 
Mar1993 
 
Not 
mentioned 
6 Included Included 3 h/ twice /wk 
158 / 0 / 158 
 (87% COPD) 
7 out of 9 3 years 80% at 3 years 
Bowen 
2000 
[16] 
10 programs inpatient 
+ 1 outpatient 
Symptomatic 
lung disease 
(89% COPD) 
Not 
mentioned 
4-12  1-3 wk 1-3 wk 
1-3 wk 
*inpatient 7-9days 
164 / 15 / 149 6 out of 9 
44 ± 12 
months 
95% at 1 year 
92% at 2 years  
85% at 3 years 
73% at 4 years 
Connor 
2001 
[17] 
1st week inpatient, and 
the rest is outpatient 
All patients with 
COPD  
 
Not 
mentioned 
8 1st wk 
Not 
included 
Circuit of mobility twice/wk. 
endurance exercise 3-6 days/wk 
170 / 0 / 170 6 out of 9 1 year 91% at 1 year 
* Studies’ quality assessed by Newcastle-Ottawa scale. Characteristics of the studies [Appendix] 
Abb ii: PR: pulmonary rehabilitation, wk: week  
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Table 3. Randomized control trials assessing the impact of pulmonary rehabilitation on mortality 
Author/ 
Year 
PR site Inclusion Exclusion PR weeks PR Education 
PR Breath 
Tech 
PR Exercise 
Train 
Total No of patients / Lost follow up 
/ Final No of patients 
Quality 
score* 
Duration 
of follow-
up 
Survival Rate 
Ries 
1995 
Inpatient 
COPD, asthmatic 
bronchitis, stable, 
no heart problem or 
disabilities 
Reversible asthma, 
current smokers don't 
want to 
quit 
8 weeks 
and 
monthly 
visit for 1 
year 
Control group 8 
weeks, rehab 
group 
8wk+1year 
Included in 
only rehab 
group 
Included in 
only rehab 
group 
Rehab 
63 / 6 / 57 
5 Yes,  
2 No 
6 year 
At 3 years: 
rehab 85% and 
control 74%. 
 At 6 years: 
rehab 67% and 
control 56%.  
P=0.32 
Control 
65 / 3 / 62 
Griffiths 
2000 
Outpatient 
Stable patient with 
FEV1 <60%, with 
less than 20% 
reversibility 
Pt. can't walk, 
cognitive impairment, 
symptomatic heart 
disease 
6 weeks for 
rehab group 
Third of the PR 
time in the rehab 
group 
Included in 
rehab group 
only 
3 half days 
/wk for rehab 
group 
Rehab 99 (83% COPD) / 7 / 92 
6 Yes, 
 1 No 
1 year 
At 1 year: rehab 
94.5% and 
control 90%. 
P=0.032 
* Studies’ quality assessed by the Cochrane Collaboration risk of bias tool. Characteristics of the studies [Appendix] 
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Online Supplements  
Table E1. PRISMA Checklist [11] 
 
Section/topic # Checklist item Reported 
on page # 
TITLE  
Title 1 Identify the report as a systematic review, meta-analysis, or both. 1 
ABSTARCT 
Structured summary 2 Provide a structured summary including, as applicable: background; objectives; data sources; study 
eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; 
conclusions and implications of key findings; systematic review registration number. 
2 
INTRODUCTION 
Rationale 3 Describe the rationale for the review in the context of what is already known.  5 
Objectives 4 Provide an explicit statement of questions being addressed with reference to participants, interventions, 
comparisons, outcomes, and study design (PICOS).  
5-6 
METHODS 
Protocol and 
registration  
5 Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, 
provide registration information including registration number.  
- 
Eligibility criteria  6 Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years 
considered, language, publication status) used as criteria for eligibility, giving rationale.  
6 
Information sources  7 Describe all information sources (e.g., databases with dates of coverage, contact with study authors to 
identify additional studies) in the search and date last searched.  
5 
Search  8 Present full electronic search strategy for at least one database, including any limits used, such that it could 
be repeated.  
5 
Study selection  9 State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if 
applicable, included in the meta-analysis).  
5-7 
Data collection process  10 Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any 
processes for obtaining and confirming data from investigators.  
5-7 
Data items  11 List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions 
and simplifications made.  
5 
Risk of bias in 
individual studies  
12 Describe methods used for assessing risk of bias of individual studies (including specification of whether 
this was done at the study or outcome level), and how this information is to be used in any data synthesis.  
5-7 
Summary measures  13 State the principal summary measures (e.g., risk ratio, difference in means).  - 
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Synthesis of results 14 Describe the methods of handling data and combining results of studies, if done, including measures of 
consistency (e.g., I2) for each meta-analysis.  
- 
Risk of bias across 
studies  
15 Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, 
selective reporting within studies).  
5-7 
Additional analyses  16 Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, 
indicating which were pre-specified.  
- 
RESULTS 
Study selection  17 Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for 
exclusions at each stage, ideally with a flow diagram.  
17 
Study characteristics  18 For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up 
period) and provide the citations.  
23 
Risk of bias within 
studies  
19 Present data on risk of bias of each study and, if available, any outcome level assessment (see item 12).  23 
Results of individual 
studies  
20 For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each 
intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.  
23 
Synthesis of results  21 Present results of each meta-analysis done, including confidence intervals and measures of consistency.  - 
Risk of bias across 
studies  
22 Present results of any assessment of risk of bias across studies (see Item 15).  23 
Additional analysis 23 Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item 
16]).  
- 
DISCUSSION 
Summary of evidence  24 Summarize the main findings including the strength of evidence for each main outcome; consider their 
relevance to key groups (e.g., healthcare providers, users, and policy makers).  
10 
Limitations  25 Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete 
retrieval of identified research, reporting bias).  
10 
Conclusions  26 Provide a general interpretation of the results in the context of other evidence, and implications for future 
research.  
10 
FUNDING  
Funding  27 Describe sources of funding for the systematic review and other support (e.g., supply of data); role of 
funders for the systematic review. 
13 
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CHARACTERISTICS OF THE INCLUDED STUDIES 
Table E2. Beauchamp 2010[15] 
Methods Cohort study 
Participants 29 diagnosed COPD patients (mean ±SD age, 
69.8±10.3y; forced expiratory volume in 1 
second, 46.3%± 22.3% predicted; 59% 
men[n=17]). 
Pulmonary rehabilitation 6-week inpatient PR which includes: Supervised 
endurance exercise training 4 to 5 times a week, 
Lower- and upper-extremity strength training 3 
times a week, Breathing exercises daily. Self-
management education and psychological and 
social support were provided through lectures, 
relaxation classes, and recreational activities at 
least twice a week for 30 minutes. 
Outcome BBS, TUG, ABC  
Risk of bias 
NOS selection *** 
NOS comparability * 
NOS ascertainment ** 
NOS: selection, comparability and ascertainment asterisks (*) with a maximum score of 4, 2, and 3, 
respectively.
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Table E3. Beauchamp 2013[14] 
Methods Cohort study. (this was a clinical trial on PR vs 
PR with balance training, for the purpose of the 
systematic review we have taken only PR only 
and treated it as cohort study) 
Participants 17 COPD patients (mean ±SD age, 
67.1±9.4y; forced expiratory volume in 1 second, 
35.4%± 17.5% predicted; 52% women [n=9]). 
Pulmonary rehabilitation 
(duration, frequency, in or out-patient, and what it 
did include) 
6-week inpatient PR which includes: Supervised 
endurance exercise training 4 to 5 times a week, 
Lower- and upper-extremity strength training 3 
times a week, Breathing exercises daily. Self-
management education and psychological and 
social support were provided through lectures, 
relaxation classes, and recreational activities at 
least twice a week for 30 minutes. 
Outcome BBS, BESTest, ABC  
Risk of bias 
NOS selection *** 
NOS comparability * 
NOS ascertainment *** 
NOS: selection, comparability and ascertainment asterisks (*) with a maximum score of 4, 2, and 3, 
respectively.
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Table E4. Gerardi 1996[18] 
Methods Cohort study 
Participants Records from 158 patients who completed 
outpatient pulmonary rehabilitation from 
Nov1989 to Mar1993 [COPD (87%), asthma 
(8%), restrictive disease (2.5%), and 
bronchiectasis (2.5%)]; (mean ±SD age 67±10y)  
Pulmonary rehabilitation 
(duration, frequency, in or out-patient, and what it 
did include) 
Outpatient 3 h/ twice weekly/ 6 weeks. 
Educational, with topics including symptom 
management, medications, compliance, breathing 
retraining, pacing, nutrition, and stress reduction. 
The remainder of the time was spent on exercise 
conditioning. Exercise included upper extremity 
training with weights and elastic bands, inspiratory 
resistive exercise, and lower extremity training 
with a treadmill and stationary bicycle. 
Outcome Survival  
Risk of bias 
NOS selection *** 
NOS comparability * 
NOS ascertainment *** 
NOS: selection, comparability and ascertainment asterisks (*) with a maximum score of 4, 2, and 3, 
respectively. 
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Table E5. Bowen 2000[16] 
Methods Cohort study 
Participants 149  patients with symptomatic lung disease (89% 
COPD; mean ±SD age 69±9y; forced expiratory 
volume in 1 second, 39%± 19% predicted; 55% 
women [n=82]). 
Pulmonary rehabilitation 
(duration, frequency, in or out-patient, and what it 
did include) 
Connecticut Pulmonary Rehabilitation 
Consortium program. 10 programs gave outpatient 
PR; 1 of them had both out and inpatient PR. PR 
includes education, breathing exercise, and 
exercise training. Duration and visit varies, [visits 
per week X program weeks, 1(2X5) 2(1X10-12) 
3(2X6-8) 4(1-3X8-12) 5(3X6) 6(2X8) 7(2X6) 8 
inpat(7-9X4) outpat(2X4) 9(3X12) 10(2X8)]   
Outcome Survival  
Risk of bias 
NOS selection **** 
NOS comparability  
NOS ascertainment ** 
NOS: selection, comparability, and ascertainment asterisks (*) with a maximum score of 4, 2, and 3, 
respectively.
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Table E6. Connor 2001[17] 
Methods Cohort study 
Participants 170 COPD patients (mean ±SD age 68.5±8.3y; 
forced expiratory volume in 1 second, 43.8%± 
17.6% predicted; 59% men [n=100]). 
Pulmonary rehabilitation 
(duration, frequency, in or out-patient, and what it 
did include) 
8 weeks. The first week of this programme 
consisted of in-patient stay of 5 days and 4 nights, 
followed by twice weekly attendances of 2 hours 
each. Education was during an in-patient stay and 
utilises a multidisciplinary team. There were 2 
types of exercise practised. A circuit of mobility 
and strength exercises was performed twice weekly 
according to an individual prescription time and 
the patient was also encouraged to perform this 
circuit at home. Endurance exercise, in the form of 
continuous walking, was performed by the patient 
at home for a minimum of 3 and maximum of 6 
days per week and a diary was completed. 
Outcome Survival  
Risk of bias 
NOS selection *** 
NOS comparability  
NOS ascertainment *** 
NOS: selection, comparability, and ascertainment asterisks (*) with a maximum score of 4, 2, and 3, 
respectively. 
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Table E7. Ries 1995[20] 
Methods Randomized Control trial 
Participants 119 stable  COPD patients, rehabilitation group 
(n=57,  mean ±SD age 61.5±8y; forced expiratory 
volume in 1 second, 1.21L± 0.55L predicted; 74% 
men [n=42]) education group (n=62, mean ±SD age 
63.6±6.3y; forced expiratory volume in 1 second, 
1.24L± 0.56L predicted; 73% men [n=45]). 
Pulmonary rehabilitation 
(duration, frequency, and what it did include) 
8-week, 2-phase comprehensive rehabilitation 
program; 1st phase involved education, physical and 
respiratory care instruction, psychosocial support, 
supervised exercise training. 2nd phase involved 
monthly follow-up visits for 1 year; this visit 
included a supervised period of exercise, group 
sessions to discuss progress and problems, and the 
introduction of maintenance techniques. 
Outcome Survival  
Risk of bias 
Based on  Cochrane Risk of  Bias Tool:  Yes* No Unclear 
Was the allocation sequence adequately 
generated? 
   
Was the sequence generation adequately 
concealed before group assignments? 
   
Was knowledge of the allocated interventions 
adequately hidden from the participants and 
personnel after participants were assigned to 
respective groups? 
   
Was knowledge of the allocated interventions 
adequately hidden from the outcome assessors 
after participants were assigned to respective 
groups? 
   
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Were incomplete outcome data adequately 
addressed? 
   
Are study reports free from suggestion of 
selective outcome reporting? 
   
Was the study apparently free of other 
problems that could put it at risk of bias? 
   
*“Yes” indicates low risk of bias; “no” indicates high risk of bias; and “unclear” indicates an unclear risk 
of bias for that specific entry. 
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Table E8. Griffiths 2000[19] 
Methods Randomized Control Trial 
Participants 200 COPD patients, rehabilitation group (n=99,  
mean ±SD age 68.2±8.2y; forced expiratory volume 
in 1 second, 39.7%± 16.2% predicted; 62% men 
[n=61]) control group (n=101, mean ±SD age 
68.3±8.1y; forced expiratory volume in 1 second, 
39.4%± 16.4% predicted; 58% men [n=59]). 
Pulmonary rehabilitation 
(duration, frequency, in or out-patient, and 
what it did include) 
Multidisciplinary outpatient PR, 3 half days per week 
for 6 weeks. Each session was about 2 hours long. 
The first third of the time was spent in educational 
activities; an exercise session followed with 
individually prescribed training programmes: 30 min 
of exercise for the legs and arms; treadmill; circuit 
training, individual dietary advice was also given. 
Outcome Survival  
Risk of bias 
Based on  Cochrane Risk of  Bias Tool:  Yes* No Unclear 
Was the allocation sequence adequately 
generated? 
   
Was the sequence generation adequately 
concealed before group assignments? 
   
Was knowledge of the allocated interventions 
adequately hidden from the participants and 
personnel after participants were assigned to 
respective groups? 
   
Was knowledge of the allocated interventions 
adequately hidden from the outcome assessors 
after participants were assigned to respective 
groups? 
   
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Were incomplete outcome data adequately 
addressed? 
   
Are reports of the study free from suggestion of 
selective outcome reporting? 
   
Was the study apparently free of other 
problems that could put it at risk of bias? 
   
*“Yes” indicates low risk of bias; “no” indicates high risk of bias; and “unclear” indicates an unclear risk 
of bias for that specific entry. 
 
